مواقع ذات صلة
الخط الساخن للخدمات الصحية للنازحين اللبنانيين 1787   
الخط الساخن لدخول المرضى الى المستشفيات 01/832700   
التسجيل لأخذ لقاح الكورونا covax.moph.gov.lb   
الخط الساخن لوزارة الصحّة العامة 1214   
هل أنت مستخدم جديد؟ قم بالتسجيل الآن
 
دعنا نساعدك
للوصول إلى هدفك.

إحصاءات أخرى

Statistics List Date Description
The High Tech Equipment Statistics  20.10.2015  
Tuberculosis Treatment Success Rate and Treatment Outcome by Site and Nationality, 2014  10.6.2015  
Compiled Literature Report on Selected Health Conditions in Lebanon 28.12.2005 This is a compilation of available literature on the epidemiology of selected health conditions in Lebanon updated till October 2004. Copies of the sited articles are available at the Ministry of Health –Department of Statistics, and will soon be published on the Ministry’s website as pdf files.
Indicators 2005 26.5.2005 These are selected health indicators updated with available figures for the year 2005.
MOH Eligibility and Utilization Statistics 2004 28.12.2004 According to the visa billing center at the MOH, and considering 2,083,000 Lebanese eligible for coverage (48.3%), the registered Inpatient visas granted sum up to only 120000 making an inpatient services utilization rate of around 6%.
Number of Children by month in 2004  28.12.2004 These are estimates of the baseline population of children aged 1-12 months by month of age applying an Infant Mortality Rate of 27 per thousand live births, assuming constant rate throughout the year. In the matrix, monthly birth data registered by the Central Administration of Statistics are used for the years 2003-2004.
Indicators 2004 28.12.2004 These are selected health indicators updated with available figures for the year 2004. These statistics were done before the release of the Living Conditions and Housing Survey done by the Central Administration of Statistics for the Year 2004, and the Preliminary data of the Papfam survey 2005. So some of the rates provided will soon be adjusted accordingly.
Deaths 2004
 
28.12.2004
Deaths lists are received monthly by the Department of Statistics from the 44 Qalams distributed in different Qadas of Lebanon through the District Physicians. A total of 11379 deaths were registered and reported in 2004. Reporting rate was 69%. As for the case of the births, deaths occuring in Beirut are not reported to the MOH for administrative reasons to be solved.
Births 2004 28.12.2004 Birth lists are received monthly by the Department of Statistics from the 44 Qalams distributed in different Qadas of Lebanon through the District Physicians. A total of 51809 biths were registered and reported in 2004. Reporting rate was 70.1%. Worth noting that births registered in Beirut are not reported to MOH. Efforts are underway to receive them.
Population less than 5 years old, estimated for the Immunization Plans 23.12.2004 The proportion of Lebanese population in different Qadas out of the total population, as well as estimates of the numbers of children less than 5 years old are provided. Data on children less than two years old are primarily important for immunization campaigns. But, so far, no survey in Lebanon was done to stratify the first five years of age into smaller groups.
Calculation of population by Qada 2003-2004  12.12.2004 Based on population proportions by Qada generated in 1996 by the Ministry Of Social Affairs, and estimates for the general population 2003-2004, this provides a rough estimate of the number of residents in each Qada, and total number of population per 5-year age groups.
Summary Statistics​ 11.11.2004 These are summary data which are updated every year, or when new statistical figures are available. Last updated in April 2005. Since population figures are always estimates, rates based on per capita calculations or birth and death rates need to be updated following the release of the Household Survey of CAS (2004).
Health Files 2004  01.01.2004 Health files are essentially provided to all children upon birth. There were 60.220 files distributed by the Department of Mother and Child at the Ministry of Health during the year 2004.
MOH granted inpatient visas during 2004 by ICD10 codes  01.01.2004 106,201 inpatient visas were granted during the year 2004 at the Visa-billing center at the MOH. The search included 8 visa centers all over Lebanon (Beirut, Nabatieh, Zgharta, Beiteddine, Chahhar Gharbi, Jbeil, Dhahr El Bechek, Kesserouan), in addition to 14 other centers that were added progressively during 2004. They  were compiled and classified by ICD10 three-character codes.
Mental Health Statistics 28.12.2003 Worth noting that the MOH does not cover medical consultations on an outpatient basis for mental patients, but rather medications for mental illnesses are provided through the Drug Dispensing Center in Karantina following a case study from a specialized committee. Also, for inpatients, coverage is based on days-stay and not on capitation basis, because of patients’ turnover during the year.
    2
التصنيف العلاجي الاسم أساسي / جنيسي التركيبة العلمية العيار الشكل الصيدلاني سعر المبيع من العموم
B02BX06 HEMLIBRA BioTech Emicizumab - 60mg/0.4ml 60mg/0.4ml Injectable solution 441,042,377 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution 224,585,721 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 150mg/ml 150mg/ml Injectable solution 716,437,779 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 105mg/0.7ml 105mg/0.7ml Injectable solution 577,741,643 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,462,901 L.L
A10AB01 HUMULIN R U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 701,486 L.L
A10AB04 HUMALOG KWIKPEN BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable solution 3,950,897 L.L
A10AB04 HUMALOG BioTech Insulin lispro - 100IU/ml 100IU/ml Injectable suspension 1,988,887 L.L
A10AD01 HUMULIN 70/30 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
A10AD04 HUMALOG MIX 50 KWIKPEN BioTech Insulin lispro solution - 50%, Insulin lispro protamine suspension - 50% 100IU/ml Injectable suspension 3,950,897 L.L
A10AD04 HUMALOG MIX 25 KWIKPEN BioTech Insulin lispro solution - 25%, Insulin lispro protamine suspension - 75% 100IU/ml Injectable suspension 3,950,897 L.L
A10AE01 HUMULIN N U-100 BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 701,486 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution L.L
L01FD01 HERZUMA BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution 89,046,707 L.L
H01AC01 HHT BioTech Somatropin recombinant - 16IU (5.32mg) 16IU (5.32mg) Injectable freeze dried powder + diluent 4,078,562 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 34,045,375 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 28,611,772 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 28,611,772 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 36,062,671 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 940,690 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4,000IU 4,000IU Injectable freeze dried substance+diluent 33,852,747 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 10,000IU 10,000IU Injectable freeze dried substance+diluent 2,490,140 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 20,000IU 20,000IU Injectable freeze dried powder + diluent 5,438,531 L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 40,000IU 40,000IU Injectable freeze dried powder + diluent 6,316,060 L.L
B01AB05 HEPAXANE 4000IU BioTech Enoxaparin sodium - 40mg/0.4ml 40mg/0.4ml Injectable solution 4,063,780 L.L
    2
Sitemap
حقوق الطبع والنشر محفوظة ل وزارة الصحة العامة ©2025